| Development and validation of a high‐quality composite real‐world mortality endpoint MD Curtis, SD Griffith, M Tucker, MD Taylor, WB Capra, G Carrigan, ... Health services research 53 (6), 4460-4476, 2018 | 176 | 2018 |
| Hypoglycaemia and accident risk in people with type 2 diabetes mellitus treated with non‐insulin antidiabetes drugs JE Signorovitch, D Macaulay, M Diener, Y Yan, EQ Wu, JB Gruenberger, ... Diabetes, obesity and metabolism 15 (4), 335-341, 2013 | 144 | 2013 |
| Opportunities and challenges in leveraging electronic health record data in oncology ML Berger, MD Curtis, G Smith, J Harnett, AP Abernethy Future oncology 12 (10), 1261-1274, 2016 | 104 | 2016 |
| Characteristics of real‐world metastatic non‐small cell lung cancer patients treated with nivolumab and pembrolizumab during the year following approval S Khozin, AP Abernethy, NC Nussbaum, J Zhi, MD Curtis, M Tucker, ... The Oncologist 23 (3), 328-336, 2018 | 99 | 2018 |
| Real‐world outcomes of patients with metastatic non‐small cell lung cancer treated with programmed cell death protein 1 inhibitors in the year following US regulatory approval S Khozin, KR Carson, J Zhi, M Tucker, SE Lee, DE Light, MD Curtis, ... The Oncologist 24 (5), 648-656, 2019 | 82 | 2019 |
| An economic model of P arkinson's disease: Implications for slowing progression in the United States SJ Johnson, MD Diener, A Kaltenboeck, HG Birnbaum, AD Siderowf Movement Disorders 28 (3), 319-326, 2013 | 75 | 2013 |
| Economic evaluation of denosumab compared with zoledronic acid in hormone-refractory prostate cancer patients with bone metastases J Xie, M Namjoshi, EQ Wu, K Parikh, M Diener, AP Yu, A Guo, KW Culver Journal of Managed Care Pharmacy 17 (8), 621-643, 2011 | 65 | 2011 |
| Direct and indirect healthcare resource utilization and costs associated with ulcerative colitis in a privately-insured employed population in the US R Cohen, M Skup, AB Ozbay, J Rizzo, M Yang, M Diener, J Chao Journal of Medical Economics 18 (6), 447-456, 2015 | 55 | 2015 |
| Effects of care management and telehealth: a longitudinal analysis using medicare data LC Baker, DS Macaulay, RA Sorg, MD Diener, SJ Johnson, HG Birnbaum Journal of the American Geriatrics Society 61 (9), 1560-1567, 2013 | 49 | 2013 |
| Costs of Parkinson’s disease in a privately insured population SJ Johnson, A Kaltenboeck, M Diener, HG Birnbaum, EB Grubb, ... Pharmacoeconomics 31, 799-806, 2013 | 46 | 2013 |
| The direct and indirect costs among US privately insured employees with hypogonadism A Kaltenboeck, S Foster, J Ivanova, M Diener, R Bergman, H Birnbaum, ... The journal of sexual medicine 9 (9), 2438-2447, 2012 | 34 | 2012 |
| Cost-effectiveness of denosumab compared with zoledronic acid in patients with breast cancer and bone metastases J Xie, M Diener, R Sorg, EQ Wu, M Namjoshi Clinical breast cancer 12 (4), 247-258, 2012 | 33 | 2012 |
| Cost effectiveness of guanfacine extended release as an adjunctive therapy to a stimulant compared with stimulant monotherapy for the treatment of attention-deficit … V Sikirica, MH Erder, J Xie, D Macaulay, M Diener, P Hodgkins, EQ Wu Pharmacoeconomics 30, e1-e15, 2012 | 26 | 2012 |
| Budget impact analysis of everolimus for the treatment of hormone receptor positive, human epidermal growth factor receptor-2 negative (HER2-) advanced breast cancer in the … J Xie, M Diener, G De, H Yang, EQ Wu, M Namjoshi Journal of Medical Economics 16 (2), 278-288, 2013 | 20 | 2013 |
| Emulating control arms for cancer clinical trials using external cohorts created from electronic health record‐derived real‐world data K Tan, J Bryan, B Segal, L Bellomo, N Nussbaum, M Tucker, AZ Torres, ... Clinical Pharmacology & Therapeutics 111 (1), 168-178, 2022 | 18 | 2022 |
| Traumatic patellar tendon rupture repair using synthetic ligament augmentation M Core, P Anract, J Raffin, DJ Biau The Journal of Knee Surgery 33 (08), 804-809, 2020 | 17 | 2020 |
| Real-world adherence and persistence associated with nebivolol or hydrochlorothiazide as add-on treatment for hypertension S Chen, D Macaulay, E Swallow, M Diener, S Farooqui, J Xie, EQ Wu Current medical research and opinion 30 (4), 637-643, 2014 | 10 | 2014 |
| Rates of PD-L1 expression testing in US community-based oncology practices (USCPs) for patients with metastatic non-small cell lung cancer (mNSCLC) receiving nivolumab (N) or … S Khozin, AP Abernethy, NC Nussbaum, J Zhi, M Curtis, M Tucker, ... Journal of Clinical Oncology 35 (15_suppl), 11596-11596, 2017 | 9 | 2017 |
| Augmenting control arms with Real-World Data for cancer trials: Hybrid control arm methods and considerations WK Tan, BD Segal, MD Curtis, SS Baxi, WB Capra, E Garrett-Mayer, ... Contemporary Clinical Trials Communications 30, 101000, 2022 | 6 | 2022 |
| Polyhedron1987, 6, 759. Google Scholar There is no corresponding record for this reference.(b) Winter, MJ MD Curtis Adv. Organomet. Chem 29, 101, 1989 | 6 | 1989 |
